Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.0%

13 terminated/withdrawn out of 329 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

31%

101 trials in Phase 3/4

Results Transparency

20%

44 of 221 completed trials have results

Key Signals

18 recruiting44 with results11 terminated

Enrollment Performance

Analytics

Phase 3

77(28.7%)

N/A

75(28.0%)

Phase 1

46(17.2%)

Phase 2

41(15.3%)

Phase 4

24(9.0%)

Early Phase 1

5(1.9%)

268Total

Phase 3(77)

N/A(75)

Phase 1(46)

Phase 2(41)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (329)

Showing 20 of 329 trials

NCT04923958Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network

Role: collaborator

NCT07339982Not ApplicableRecruiting

Supermarket Labelling and Taxation Study

Role: collaborator

NCT05600062Not ApplicableActive Not Recruiting

Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)

Role: collaborator

NCT04316494Phase 4Terminated

Hydroxychloroquine in ANCA Vasculitis Evaluation

Role: collaborator

NCT03640377Phase 2Completed

Praziquantel in Children Under Age 4

Role: collaborator

NCT07103681Recruiting

White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)

Role: collaborator

NCT06624787Not ApplicableNot Yet Recruiting

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Role: collaborator

NCT06678022Not ApplicableRecruiting

Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples

Role: collaborator

NCT06478277Recruiting

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

Role: collaborator

NCT04349826Phase 4Completed

The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

Role: collaborator

NCT04241276Phase 2Active Not Recruiting

A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

Role: collaborator

NCT07300683Phase 1Recruiting

Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma

Role: collaborator

NCT04843761Phase 3Completed

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Role: collaborator

NCT06729593Phase 3Completed

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Role: collaborator

NCT06729606Phase 3Completed

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Role: collaborator

NCT07207057Phase 3Recruiting

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

Role: collaborator

NCT05660928Not ApplicableCompleted

Control of Hypertension and diAbetes in MINas Gerais

Role: collaborator

NCT02847338Phase 4Completed

Comparison of Optimal Hypertension Regimens

Role: collaborator

NCT03684278Phase 2Recruiting

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

Role: collaborator

NCT05685810Active Not Recruiting

Genetic Determinants of Kidney Disease in People of African Ancestry With HIV

Role: collaborator